Nanotechnology in Medical Applications: The Global Market
The global nanomedical market was valued at $134.4 billion in 2016. This market is projected to grow at a compound annual growth rate (CAGR) of 14.0% from 2017-2022, and should reach $293.1 billion by 2022 from $151.9 billion in 2017.
An overview of the global markets for nanotechnology used in medical applications
Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022
A review of technologies involved, in-depth analysis of applications in practice, and evaluation of future or potential applications
Information on many significant products in which the nano dimension has made a significant contribution to product effectiveness
A look at the regulatory environment, healthcare policies, demographics, and other factors that directly affect nanotechnology used in medicine
Analysis of the market's dynamics, specifically growth drivers, inhibitors, and opportunities
Coverage of strategies employed by companies specializing in nanomedicine to meet the challenges of this highly competitive market
This report discusses the implications of technology and commercial trends in the context of the current size and growth of the pharmaceutical market, both in global terms and analyzed by the most important national markets. The important technologies supporting nanomedicine are reviewed, and the nature and structure of the nanomedicine industry are discussed with profiles of the leading 60+ companies, including recent merger and acquisition (M&A) activity. Five-year sales forecasts are provided for the national markets including the major therapeutic categories of products involved. Specific product categories quantified include diagnostics, cancer, CNS, anti-infective agents, cardiovasculars and anti-inflammatories.